Blood levels of haloperidol and clinical outcome in schizophrenia. 1994

S Doddi, and A Rifkin, and B Karajgi, and T Cooper, and M Borenstein
Department of Psychiatry, Our Lady of Mercy Medical Center, Bronx, NY 10466.

Haloperidol levels in blood were measured in 55 acutely psychotic inpatients with schizophrenia, who were randomly assigned to three fixed doses of oral haloperidol. Nineteen of these subjects received 10 mg/day, 18 received 30 mg/day, and 18 of them received 80 mg/day. All of the subjects were treated under double-blind conditions for 6 weeks or until remission. Haloperidol and reduced haloperidol levels were measured in plasma and red blood cells at the end of 2, 4, and 6 weeks of treatment. There were statistically significant linear correlations between the dose of haloperidol and levels in blood. An examination of data for linear and curvilinear relationships between levels in blood and clinical response did not yield any statistically significant relations. The data did not support the concept of a "therapeutic window." The ratio of reduced haloperidol to haloperidol levels in plasma or red blood cells did not yield any statistically significant correlations to clinical outcome.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D005260 Female Females
D006220 Haloperidol A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279) Haldol
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

S Doddi, and A Rifkin, and B Karajgi, and T Cooper, and M Borenstein
January 1988, Progress in neuro-psychopharmacology & biological psychiatry,
S Doddi, and A Rifkin, and B Karajgi, and T Cooper, and M Borenstein
January 1983, Psychopharmacology,
S Doddi, and A Rifkin, and B Karajgi, and T Cooper, and M Borenstein
May 1992, Archives of general psychiatry,
S Doddi, and A Rifkin, and B Karajgi, and T Cooper, and M Borenstein
October 1982, Psychopharmacology bulletin,
S Doddi, and A Rifkin, and B Karajgi, and T Cooper, and M Borenstein
December 1990, Journal of clinical psychopharmacology,
S Doddi, and A Rifkin, and B Karajgi, and T Cooper, and M Borenstein
March 1994, Progress in neuro-psychopharmacology & biological psychiatry,
S Doddi, and A Rifkin, and B Karajgi, and T Cooper, and M Borenstein
August 1982, The American journal of psychiatry,
S Doddi, and A Rifkin, and B Karajgi, and T Cooper, and M Borenstein
February 1985, Biological psychiatry,
S Doddi, and A Rifkin, and B Karajgi, and T Cooper, and M Borenstein
October 1995, Archives of general psychiatry,
S Doddi, and A Rifkin, and B Karajgi, and T Cooper, and M Borenstein
August 1989, Biological psychiatry,
Copied contents to your clipboard!